Compounded tirzepatide for weight loss explained: legal status, costs, dosing, and safety, plus what to ask a prescriber before you start a program.
Compounded tirzepatide is a pharmacy-made version of the active ingredient in Zepbound and Mounjaro, usually sold as a liquid you inject once a week. It is not FDA-approved, and since federal regulators declared the tirzepatide shortage over in December 2024, most large-scale compounding of the drug is no longer permitted in the United States. Before you pay for a vial of compounded tirzepatide for weight loss, confirm the current legal status, the pharmacy's license, and the prescriber's credentials.
What Compounded Tirzepatide Actually Is
Tirzepatide is a dual GIP and GLP-1 receptor agonist, meaning it mimics two gut hormones that influence appetite, digestion speed, and blood sugar. That dual action is why it produced greater average weight loss than single-hormone drugs in its clinical trials.
Brand-name tirzepatide comes in two FDA-approved products:
- Mounjaro — approved in 2022 for type 2 diabetes.
- Zepbound — approved in 2023 for chronic weight management in adults with obesity, or with excess weight plus at least one related condition.
Compounding pharmacies stepped in when brand supply could not meet demand. That shortage has ended, and the tirzepatide for weight loss market has shifted toward brand-name vials, manufacturer self-pay programs, and a shrinking number of compounded sellers.
Compounded vs. Brand-Name Tirzepatide at a Glance
| Factor | Brand-name (Zepbound or Mounjaro) | Compounded tirzepatide |
|---|---|---|
| FDA approval | Yes, for specific uses | No — not FDA-approved |
| Prescription required | Yes | Yes, though telehealth screening varies |
| Typical monthly cost | About $350–$500 with self-pay vials; more for pens | Roughly $150–$500, depending on the seller |
| Quality oversight | FDA-regulated manufacturing | State board and pharmacy oversight only |
| Insurance coverage | Sometimes, with prior authorization | Almost never |
Cost and access drive most of the interest in compounding. Insurance coverage for obesity treatment remains inconsistent, and list prices for brand-name pens have exceeded $1,000 per month, which is why self-pay vials changed the math for many patients.
Typical Dosing and Titration
Providers generally start low and increase the dose only when side effects stay tolerable. A standard tirzepatide dosage chart for weight loss follows roughly this schedule:
| Weeks | Weekly dose | Notes |
|---|---|---|
| 1–4 | 2.5 mg | Starter dose; not intended for weight loss on its own |
| 5–8 | 5 mg | First maintenance-level dose |
| 9–12 | 7.5 mg | Optional step |
| 13–16 | 10 mg | Optional step |
| 17–20 | 12.5 mg | Optional step |
| 21+ | 15 mg | Maximum approved dose |
Compounded vials are labeled in milligrams per milliliter while insulin-style syringes are marked in units, so many patients use a tirzepatide dosage calculator for weight loss to double-check each draw. Unit-to-milligram conversion mistakes are among the most frequently reported problems with compounded injectables.
Legal Status and Cost in the United States
In December 2024, the FDA resolved the tirzepatide shortage, which removed the main legal basis for 503A and 503B pharmacies to make copies of the drug at scale. Enforcement dates have moved repeatedly because of court challenges, and some pharmacies still sell formulations that add ingredients such as vitamin B12.
Because the rules keep changing, check the FDA's current guidance before ordering anything. Reputable telehealth prescribers will tell you which pharmacy they use, whether that pharmacy is licensed in your state, and what happens if the compounded product becomes unavailable.
For a closer look at how the brand-name diabetes and obesity versions compare, see tirzepatide vs mounjaro for weight loss.
Safety, Side Effects, and What to Watch
Common side effects include nausea, vomiting, diarrhea, constipation, burping, and injection-site reactions. Most of these ease after the first few weeks of each dose increase.
Serious risks reported with tirzepatide-class drugs include pancreatitis, gallbladder disease, slowed stomach emptying, low blood sugar when combined with insulin or sulfonylureas, and harm to a fetus. Compounded products carry additional uncertainty because the FDA does not review their safety, effectiveness, purity, or potency.
Head-to-head trial results and how to interpret them are covered in tirzepatide vs semaglutide which is better for weight loss.
Compounded drugs are not generic equivalents. A compounded product can contain the same active ingredient as an approved drug and still differ in strength, purity, and how it behaves in the body.
Questions to Ask Before You Start
- Which pharmacy compounds this product, and is it licensed in my state?
- What is the concentration of the vial, and how many units equal my prescribed dose?
- How will you monitor side effects, and what is the plan if I need to stop?
- What happens to my cost and supply if compounding is halted?
- Are there interactions with my current medications, especially insulin, blood thinners, or oral contraceptives?
Anyone with a history of pancreatitis, gallbladder disease, kidney problems, or a personal or family history of medullary thyroid cancer should discuss those risks with a clinician before starting. This article is informational and is not a substitute for personalized medical advice.
Frequently Asked Questions
Is compounded tirzepatide FDA-approved for weight loss?
No. Compounded tirzepatide is not FDA-approved, and the agency does not review compounded drugs for safety, effectiveness, or quality. Zepbound and Mounjaro are the only FDA-approved tirzepatide products, and both require a prescription.
How much does compounded tirzepatide cost per month?
Compounded tirzepatide has typically sold for roughly $150 to $500 per month, depending on the pharmacy, dose, and any membership or consultation fees. Brand-name self-pay vials run about $350 to $500 monthly for lower doses, and insurance almost never covers compounded versions.
Is compounded tirzepatide as effective as Zepbound?
There are no head-to-head trials comparing compounded tirzepatide with Zepbound, so effectiveness claims are unproven. The active ingredient may be the same molecule, but strength, purity, and handling can vary, and the FDA has warned about dosing errors and adverse events linked to compounded versions.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.